Biofrontera AG American Depositary Shares
BFRA
BFRA was delisted on the 4th of March, 2022.
5 hedge funds and large institutions have $216K invested in Biofrontera AG American Depositary Shares in 2021 Q3 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
29% less capital invested
Capital invested by funds: $306K → $216K (-$90K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$1.01K |
| 2 |
1CM
1492 Capital Management
Milwaukee,
Wisconsin
|
+$631 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$33.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$14.6K |
BFRA Hedge Fund Activity: Q3 2021 in Review
5 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Biofrontera AG American Depositary Shares (BFRA) for Q3 2021, worth a combined $216K — down 29% from $306K a quarter earlier.
Fund positioning in BFRA was balanced in Q3 2021: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, adding an estimated $1.01K. The largest seller was Morgan Stanley, cutting an estimated $33.4K.
- 5 institutional investors held Biofrontera AG American Depositary Shares (BFRA) as of Q3 2021, unchanged from Q2 2021.
- Funds reported $216K of Biofrontera AG American Depositary Shares stock for Q3 2021, down 29% quarter-over-quarter.
- 0 funds opened new Biofrontera AG American Depositary Shares positions in Q3 2021 and 0 closed out.
- The largest Biofrontera AG American Depositary Shares buyer in Q3 2021 was UBS Group, an estimated $1.01K added.
- The largest Biofrontera AG American Depositary Shares seller in Q3 2021 was Morgan Stanley, an estimated $33.4K sold.
Based on aggregated 13F filings for Q3 2021.